Similar articles for PMID: 9440032

Year	Number of Results
1989	1
1993	5
1994	6
1995	7
1996	3
1997	4
1999	4
2000	2
2001	7
2002	1
2003	3
2004	3
2005	9
2006	2
2007	6
2008	4
2009	4
2010	1
2011	1
2012	1
2013	1
2014	3
2015	4
2016	2
2017	2
2018	5
2019	2
2021	2
2022	1
2024	0

1

Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas.

Lamszus K, Meyerhof W, Westphal M. Lamszus K, et al. J Neurooncol. 1997 Dec;35(3):353-64. doi: 10.1023/a:1005893223090. J Neurooncol. 1997. PMID: 9440032 Review.

2

Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.

Barbieri F, Pattarozzi A, Gatti M, Porcile C, Bajetto A, Ferrari A, Culler MD, Florio T. Barbieri F, et al. Endocrinology. 2008 Sep;149(9):4736-46. doi: 10.1210/en.2007-1762. Epub 2008 Jun 19. Endocrinology. 2008. PMID: 18566118

3

Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.

Barbieri F, Pattarozzi A, Gatti M, Aiello C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD, Florio T. Barbieri F, et al. Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1078-88. doi: 10.1152/ajpendo.00292.2009. Epub 2009 Aug 25. Am J Physiol Endocrinol Metab. 2009. PMID: 19706788 Free article.

4

Characterization of somatostatin receptor subtypes.

Bruns C, Weckbecker G, Raulf F, Lübbert H, Hoyer D. Bruns C, et al. Ciba Found Symp. 1995;190:89-101; discussion 101-10. doi: 10.1002/9780470514733.ch6. Ciba Found Symp. 1995. PMID: 7587655 Review.

5

Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.

Hofland LJ, van der Hoek J, Feelders R, van der Lely AJ, de Herder W, Lamberts SW. Hofland LJ, et al. J Endocrinol Invest. 2005;28(11 Suppl International):36-42. J Endocrinol Invest. 2005. PMID: 16625843 Review.

6

Somatostatin and its receptor family.

Patel YC. Patel YC. Front Neuroendocrinol. 1999 Jul;20(3):157-98. doi: 10.1006/frne.1999.0183. Front Neuroendocrinol. 1999. PMID: 10433861 Review.

7

Molecular pharmacology of somatostatin receptors.

Viollet C, Prévost G, Maubert E, Faivre-Bauman A, Gardette R, Kordon C, Loudes C, Slama A, Epelbaum J. Viollet C, et al. Fundam Clin Pharmacol. 1995;9(2):107-13. doi: 10.1111/j.1472-8206.1995.tb00269.x. Fundam Clin Pharmacol. 1995. PMID: 7628822 Review.

8

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

Buscail L, Delesque N, Estève JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, et al. Buscail L, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2315-9. doi: 10.1073/pnas.91.6.2315. Proc Natl Acad Sci U S A. 1994. PMID: 7907795 Free PMC article.

9

Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.

Shimon I. Shimon I. Endocrine. 2003 Apr;20(3):265-9. doi: 10.1385/ENDO:20:3:265. Endocrine. 2003. PMID: 12721506 Review.

10

Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.

Taboada GF, Luque RM, Bastos W, Guimarães RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR. Taboada GF, et al. Eur J Endocrinol. 2007 Jan;156(1):65-74. doi: 10.1530/eje.1.02313. Eur J Endocrinol. 2007. PMID: 17218727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year